Related links
FORM FDA 1572
FDA Form 1572 is a Statement of Investigator required for clinical drug investigations. It includes investigator details, qualifications, facility information, IRB, and protocol details.
Learn more
Assessing User Fees Under the Biosimilar
Form Approved: OMB No. 0910-0693. Expiration Date: October 31, 2020. See PRA Statement on last page. Section I: Applicant Information. 1. Applicant Name. Former
Learn more